beta-Amyloid Aggregation Inhibitors for the Treatment of Alzheimer Disease Dream or Reality?

Author: Talaga P.

Source: Mini Reviews in Medicinal Chemistry, Volume 1, Number 2, July 2001 , pp. 175-186(12)

Publisher: Bentham Science Publishers

Key:

- Free Content

- New Content

- Subscribed Content

- Free Trial Content

Abstract:

Amyloid (A beta) deposition remains a hallmark in the pathology of Alzheimer disease (AD). Important drug discovery efforts dedicated to the inhibition of the polymerization process leading to amyloid neurotoxicity are pursued by academic groups and the pharmaceutical industry as a potential preventive treatment for AD. The aim of this review is to up-date current knowledge on the amyloid aggregation process and the various available peptidic and non-peptidic A beta aggregation inhibitors.

Keywords: Aggregation Inhibitors; Alzheimers Disease; Anti-inflammatory agents; Antioxidants; Neurotrophic; Ab Aggregation Inhibition; AMYLOID AGGREGATION INHIBITORS; Thyrotrophin releasing hormone (TRH); Melatonin; Hexadecyl-N-methylpiperidinium (HMP) bromide

Language: English

Document Type: Review article

DOI: 10.2174/1389557013407098

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$55.10 plus tax Refund Policy